SCHEMBL4772585

SCHEMBL4772585

Nc1nc(N)c(-c2cc(F)c(Oc3ccnc4[nH]cc(Br)c34)c(F)c2)c(C(F)(F)F)n1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ROCK2 O75116 8/20 0.49
CYP3A4 P08684 4/20 0.45
CDC7 O00311 1/20 0.45
CHEK1 O14757 1/20 0.45
AURKA O14965 1/20 0.45
PDPK1 O15530 1/20 0.45
DAPK3 O43293 1/20 0.45
DYRK3 O43781 1/20 0.45
CACNA1F O60840 1/20 0.45
RAF1 P04049 1/20 0.45
ERBB2 P04626 1/20 0.45
NTRK1 P04629 1/20 0.45
INSR P06213 1/20 0.45
CDK1 P06493 1/20 0.45
FES P07332 1/20 0.45
CSF1R P07333 1/20 0.45
LYN P07948 1/20 0.45
MET P08581 1/20 0.45
ROS1 P08922 1/20 0.45
KIT P10721 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4765307 0.89 ROCK2 (0.63) ROCK2CYP3A4CDC7CHEK1AURKA
SCHEMBL5097084 0.89 ROCK2 (0.58) ROCK2CYP3A4CDC7CHEK1AURKA
SCHEMBL4769909 0.86 ROCK2 (0.47) ROCK2CYP3A4CDC7CHEK1AURKA
SCHEMBL4765301 0.79 ROCK2 (0.57) ROCK2CYP3A4CDC7CHEK1AURKA
SCHEMBL4770061 0.79 ROCK2 (0.53) ROCK2CYP3A4CDC7CHEK1AURKA
SCHEMBL4768178 0.78 TBK1 (0.52) ROCK2CYP3A4CDC7CHEK1AURKA
SCHEMBL14176466 0.77 ROCK2 (0.80) ROCK2CYP3A4CDC7CHEK1AURKA
SCHEMBL4775724 0.77 ROCK2 (0.57) ROCK2CYP3A4CDC7CHEK1AURKA
SCHEMBL4768374 0.76 ROCK2 (0.42) ROCK2CYP3A4CDC7CHEK1AURKA
SCHEMBL4774368 0.75 ROCK2 (0.47) ROCK2CYP3A4CDC7CHEK1AURKA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1751153-B1 HETARYLOXY-SUBSTITUTED PHENYLAMINO PYRIMIDINES AS RHO KINASE INHIBITORS BAYER HEALTHCARE AG (DE) 2008-12-03 EP disclosed